{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 1-[(8''S'',9''S'',10''R'',13''S'',14''S'',17''S'')-3-cyclopentyloxy-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1''H''-cyclopenta[''a'']phenanthren-17-yl]ethanone
| image = Quingestrone.svg
| width = 250px

<!--Clinical data-->
| tradename = Enol-Luteovis
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = Rx-only
| routes_of_administration = [[Oral_administration|By mouth]]
| class = [[Progestin|Progestin]]; [[Progestogen|Progestogen]]; [[Progestogen_ether|Progestogen ether]]; [[Neurosteroid|Neurosteroid]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 67-95-8
| CAS_supplemental = 
| ATC_prefix = G03
| ATC_suffix = A
| PubChem = 9929903
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 8105534
| UNII = 0612VZ9I5Z
| ChEMBL = 2104568
| KEGG = D05680
| synonyms = W-3399; Progesterone 3-cyclopentyl enol ether; PCPE; 3-Cyclopentyloxypregna-3,5-dien-20-one

<!--Chemical data-->
| C=26 | H=38 | O=2
| molecular_weight = 382.579 g/mol
| SMILES = CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(=C4)OC5CCCC5)C)C
| StdInChI_Ref = 
| StdInChI = 1S/C26H38O2/c1-17(27)22-10-11-23-21-9-8-18-16-20(28-19-6-4-5-7-19)12-14-25(18,2)24(21)13-15-26(22,23)3/h8,16,19,21-24H,4-7,9-15H2,1-3H3/t21-,22+,23-,24-,25-,26+/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = XAVRSHOUEXATJE-FBQZJRKBSA-N
}}
<!-- Definition and medical uses -->
'''奎孕酮'''（{{lang-en|Quingestrone}}）也称为'''孕酮-3-烯醇环戊醚'''（progesterone 3-cyclopentyl enol ether，'''PCPE'''）是一种[[黄体制剂|黄体制剂]]药物，在1962年起用作[[复合口服避孕药|复合口服避孕药]]，但在[[意大利|意大利]]等国已不再使用<ref name="Elks2014">{{cite book | doi=10.1007/978-1-4757-2085-3 | url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1058 | title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies | publisher=Springer | date=14 November 2014 | author=J. Elks | page=1058 | isbn=978-1-4757-2085-3 | oclc=898564124}}</ref><ref name="Group1965">{{cite book | url=https://books.google.com/books?id=-5hsAAAAMAAJ | title=Handbook on oral contraception | publisher=Little, Brown | author=International Planned Parenthood Federation. Medical Committee. Oral Advisory Group | year=1965 | page=18 | oclc=2717593}}</ref><ref name="pmid3559100">{{cite journal | title=Prolonged cholestasis after cyproheptadine-induced acute hepatitis | journal=J. Clin. Gastroenterol. | vauthors=Larrey D, Geneve J, Pessayre D, Machayekhi JP, Degott C, Benhamou JP | year=1987 | volume=9 | issue=1 | pages=102–4 | pmid=3559100 | issn=0192-0790 | doi=10.1097/00004836-198702000-00026|quote=She had been taking an oral contraceptive combining ethinylestradiol and quingestrone since 1980.}}</ref><ref name="Hawkins1974">{{cite book|author=Denis Frank Hawkins|title=Obstetric therapeutics: clinical pharmacology and therapeutics in obstetric practice|url=https://books.google.com/books?id=osNsAAAAMAAJ|year=1974|publisher=Baillière Tindall|isbn=978-0-7020-0471-1|pages=129, 138, 145}}</ref><ref name="Bentley1980">{{cite book|author=P. J. Bentley|title=Endocrine Pharmacology: Physiological Basis and Therapeutic Applications|url=https://books.google.com/books?id=W6M9AAAAIAAJ&pg=PA274|year=1980|publisher=CUP Archive|isbn=978-0-521-22673-8|pages=274–}}</ref>

<!-- Side effects and mechanism -->
奎孕酮作为一种[[黄体制剂|黄体制剂]]（人工合成的[[孕激素|孕激素]]），能作为[[孕酮|孕酮]]的[[靶点_(生物学)|生物学靶点]]——[[孕酮受体|孕酮受体]]的[[激动剂|激动剂]]<ref name="Elks2014" />，另外也具有较弱的[[糖皮质激素|糖皮质激素]]活性。


==参考文献==
{{Reflist}}

{{Progestogens and antiprogestogens}}
[[Category:孕激素类|Category:孕激素类]]
[[Category:孕烷|Category:孕烷]]